Document and Entity Information
Document and Entity Information | 6 Months Ended |
Feb. 29, 2016shares | |
Document Type | 10-Q |
Amendment Flag | false |
Document Period End Date | Feb. 29, 2016 |
Trading Symbol | enrt |
Entity Registrant Name | Enertopia Corp. |
Entity Central Index Key | 1,346,022 |
Current Fiscal Year End Date | --08-31 |
Entity Filer Category | Smaller Reporting Company |
Entity Common Stock, Shares Outstanding | 71,608,460 |
Entity Current Reporting Status | Yes |
Entity Voluntary Filers | No |
Entity Well Known Seasoned Issuer | No |
Document Fiscal Year Focus | 2,016 |
Document Fiscal Period Focus | Q2 |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Feb. 29, 2016 | Aug. 31, 2015 |
Current | ||
Cash and cash equivalents | $ 38,345 | $ 84,157 |
Marketable securities | 42,990 | 181,950 |
Accounts receivable | 4,755 | 23,653 |
Prepaid expenses and deposit | 13,288 | 15,832 |
Inventory | 31,539 | 38,335 |
Total current assets | 130,917 | 343,927 |
Non-Current | ||
Long term investments - GSWPS | 1 | 1 |
Other Long term investments | 22,182 | 22,182 |
Total Assets | 153,100 | 366,110 |
Current | ||
Accounts payable | 249,788 | 208,749 |
Deferred Revenues | 20,000 | 40,000 |
Due to related parties | 108,098 | 76,288 |
Total Current Liabilities | 377,886 | 325,037 |
STOCKHOLDERS' EQUITY | ||
Share capital Authorized: 200,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 71,608,460 common shares at February 29, 2016 and August 31,2015: 71,508,460 | 71,608 | 71,508 |
Additional paid-in capital | 11,922,668 | 11,884,661 |
Shares to be returned | 0 | 0 |
Accumulated deficit | (12,219,062) | (11,915,096) |
Total Stockholders' Equity | (224,786) | 41,073 |
Total Liabilities and Stockholders' Equity | $ 153,100 | $ 366,110 |
BALANCE SHEETS (Parenthetical)
BALANCE SHEETS (Parenthetical) - $ / shares | Feb. 29, 2016 | Aug. 31, 2015 |
Common Stock, Shares Authorized | 200,000,000 | 200,000,000 |
Common Stock, Par Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares, Issued | 71,608,460 | 71,508,460 |
Common Stock, Shares, Outstanding | 71,608,460 | 71,508,460 |
STATEMENTS OF STOCKHOLDERS' EQU
STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) | COMMON STOCK [Member] | ADDITIONAL PAID-IN CAPITAL [Member] | STOCK TO BE RETURNED [Member] | ACCUMULATED DEFICIT [Member] | Total |
Beginning Balance at Aug. 31, 2014 | $ 90,871 | $ 14,070,611 | $ (1,713,145) | $ (10,765,663) | $ 1,682,673 |
Beginning Balance (Shares) at Aug. 31, 2014 | 90,870,747 | ||||
WOM JV Termination, shares back to Treasury | $ (15,127) | (1,667,418) | 1,682,545 | ||
WOM JV Termination, shares back to Treasury (Shares) | (15,127,287) | ||||
Shares returned for contract cancellation C. Hornung | $ (90) | (30,510) | $ 30,600 | ||
Shares returned for contract cancellation C. Hornung (Shares) | (90,000) | ||||
Stock Based Compensation | 177,596 | 177,596 | |||
Shares issued for PP on January 30 | $ 1,665 | 70,400 | 72,065 | ||
Shares issued for PP on January 30 (Shares) | 1,665,000 | ||||
Shares issued for PP on March 12 | $ 590 | 25,582 | 26,172 | ||
Shares issued for PP on March 12 (Shares) | 590,000 | ||||
Shares to be returned for JV termination | $ (6,400) | (761,600) | (768,000) | ||
Shares to be returned for JV termination (Shares) | (6,400,000) | ||||
Comprehensive income (loss): (Loss) for the year | (1,149,433) | (1,149,433) | |||
Ending Balance at Aug. 31, 2015 | $ 71,508 | 11,884,661 | (11,915,096) | 41,073 | |
Ending Balance (Shares) at Aug. 31, 2015 | 71,508,460 | ||||
Stock Based Compensation | 37,107 | 37,107 | |||
Stock issued for Consulting Agreement | $ 100 | 900 | 1,000 | ||
Stock issued for Consulting Agreement (Shares) | 100,000 | ||||
Comprehensive income (loss): (Loss) for the year | (303,966) | (303,966) | |||
Ending Balance at Feb. 29, 2016 | $ 71,608 | $ 11,922,668 | $ (12,219,062) | $ (224,786) | |
Ending Balance (Shares) at Feb. 29, 2016 | 71,608,460 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | ||
Feb. 29, 2016 | Feb. 28, 2015 | Feb. 29, 2016 | Feb. 28, 2015 | |
Revenue | ||||
Net Sales | $ 2,204 | $ 0 | $ 14,014 | $ 0 |
Cost of Product Sales | 1,499 | 0 | 7,515 | 0 |
Gross Profit | 705 | 0 | 6,499 | 0 |
Expenses | ||||
Accounting and audit | (12,039) | 5,212 | 27,961 | 40,628 |
Sales & Marketing | 21 | 183 | 1,801 | 183 |
Advertising & Promotions | 10,002 | 83,060 | 20,563 | 131,810 |
Bank charges and interest expense | 2,629 | 771 | 4,616 | 1,164 |
Consulting/Stock Based Compensation | 50,605 | 193,358 | 141,486 | 591,555 |
Fees and dues | 12,952 | 15,902 | 22,250 | 24,654 |
Insurance | 4,428 | 1,826 | 8,861 | 3,875 |
Investor relations | 1,363 | 11,738 | 6,368 | 18,473 |
Legal and professional | 4,083 | 5,444 | 25,781 | 28,965 |
Office and miscellaneous | 7,746 | 1,487 | 5,942 | 7,704 |
Research and Development | 1,460 | 5,364 | 4,608 | 5,364 |
Rent | 5,324 | 21,257 | 11,472 | 45,352 |
Telephone | 815 | 1,056 | 1,345 | 1,845 |
Training & Conferences | 0 | 394 | 666 | 394 |
Travel | 959 | 3,059 | 1,696 | 5,688 |
Total expenses | 90,348 | 350,111 | 285,416 | 907,654 |
(Loss) for the period before other items | (89,643) | (350,111) | (278,917) | (907,654) |
Other income (expense) | ||||
Other income | 10,000 | 10,000 | 20,000 | 20,000 |
MMJ license expenses | 0 | 0 | 0 | (384,000) |
Gain and Loss on marketable securities | (74,435) | 0 | (45,049) | (30,000) |
Net loss and comprehensive loss for the period | $ (154,078) | $ (340,111) | $ (303,966) | $ (1,301,654) |
Basic and diluted income (loss) per share | $ 0 | $ 0 | $ 0 | $ (0.02) |
Weighted average number of common shares outstanding - basic and diluted | 71,536,238 | 75,921,710 | 71,522,272 | 79,546,951 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 6 Months Ended | |
Feb. 29, 2016 | Feb. 28, 2015 | |
Cash flows used in operating activities | ||
Net (loss) | $ (303,966) | $ (1,301,654) |
Changes to reconcile net loss to net cash used in operating activities | ||
Consulting - Stock based compensation | 37,107 | 177,596 |
Shares issued for service | 1,000 | 0 |
MMJ expenses | 0 | 384,000 |
Loss on marketable securities | 45,049 | 30,000 |
Change in non-cash working capital items: | ||
Accounts receivable | 18,898 | (15,670) |
Prepaid expenses and deposit | 2,544 | 128,884 |
Inventory | 6,796 | 0 |
Deferred revenue | (20,000) | (20,000) |
Accounts payable | 41,039 | 7,098 |
Due to related parties | 31,810 | 0 |
Net cash (used in) operating activities | (139,723) | (609,746) |
Cash flows from (used in) investing activities | ||
Proceeds from sale of marketable securities | 93,911 | 0 |
Net cash from investing activities | 93,911 | 0 |
Cash flows from financing activities | ||
Net proceeds from subscriptions received | 0 | 92,392 |
Net cash from financing activities | 0 | 92,392 |
Increase (Decrease) in cash and cash equivalents | (45,812) | (517,354) |
Cash and cash equivalents, beginning of period | 84,157 | 888,122 |
Cash and cash equivalents, end of period | 38,345 | 370,768 |
Supplemental information of cash flows | ||
Interest paid in cash | 0 | 0 |
Income taxes paid in cash | $ 0 | $ 0 |
ORGANIZATION
ORGANIZATION | 6 Months Ended |
Feb. 29, 2016 | |
ORGANIZATION [Text Block] | 1. ORGANIZATION The unaudited condensed financial statements for the period ended February 29, 2016 included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These unaudited condensed financial statements should be read in conjunction with the August 31, 2015 audited annual financial statements and notes thereto. The Company was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. The Company was an independent natural resource company engaged in the exploration, development and acquisition of natural resources in the United States and Canada. In the fiscal year 2010, the Company shifted its strategic plan from its non-renewal energy operations to its planned renewal energy operations and natural resource acquisition and development. In late summer of 2013, the Company added another business sector in its entrance to alternative health and wellness and is considered a development stage company. The Company has offices in Vancouver and Kelowna, B.C., Canada. Effective September 25, 2009, the Company effected one (1) for two (2) share consolidation of our authorized and issued and outstanding common stock. On February 8, 2010, the Company changed its name from Golden Aria Corp. to Enertopia Corp. On February 22, 2010, the Company increased its authorized share capital to 200,000,000 common shares. |
GOING CONCERN UNCERTAINTY
GOING CONCERN UNCERTAINTY | 6 Months Ended |
Feb. 29, 2016 | |
GOING CONCERN UNCERTAINTY [Text Block] | 2. GOING CONCERN UNCERTAINTY The accompanying unaudited condensed financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business for the foreseeable future. The Company incurred a net loss of $303,966 for the six months ended February 29, 2016 [net loss of $1,301,654 for the six months ended February 29, 2015] and as at February 29, 2016 has incurred cumulative losses of $12,219,062 that raises substantial doubt about its ability to continue as a going concern. Management has been able, thus far, to finance the operations through equity financing and cash on hand. There is no assurance that the Company will be able to continue to finance the Company on this basis. In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to obtain additional financing as may be required, to receive the continued support of the Company’s shareholders, and ultimately to obtain successful operations. There are no assurances that we will be able to obtain further funds required for our continued operations. As noted herein, we are pursuing various financing alternatives to meet our immediate and long-term financial requirements. There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will be unable to conduct our operations as planned, and we will not be able to meet our other obligations as they become due. In such event, we will be forced to scale down or perhaps even cease our operations. There is significant uncertainty as to whether we can obtain additional financing. These unaudited condensed financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying unaudited condensed financial statements. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
Feb. 29, 2016 | |
SIGNIFICANT ACCOUNTING POLICIES [Text Block] | 3. SIGNIFICANT ACCOUNTING POLICIES a) Basis of Presentation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2015. The Company early adopted Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. This standard removes all incremental financial reporting requirements from U.S. generally accepted accounting principles for development stage entities, including the removal of Topic 915 from the FASB Accounting Standards Codification. Upon adoption, the Company no longer reports its operations as a development stage entity and eliminated all inception to date information. b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to revenue recognition, inventory valuation, and stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions. c) Recently Adopted Accounting Pronouncements In June 2014, the FASB issued Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation (“ASU 2014-10”). The amendments in ASU 2014-10 remove all incremental financial reporting requirements from GAAP for development stage entities, including the removal of Topic 915, Development Stage Entities, from the FASB Accounting Standards Codification. ASU 2014-10 is effective for the first annual period beginning after December 15, 2014. Early adoption is permitted and the Company adopted ASU 2014-10 in the fourth quarter of 2015 which consisted principally of removing inception to date information on the Company’s statements of operations, equity and cash flows as well as other inception to date disclosures in the notes to its financial statements. d) New Accounting Pronouncements FASB ASU 2014-09, “Revenue from Contracts with Customers,” was issued May 2014 and updates the principles for recognizing revenue. The ASU will supersede most of the existing revenue recognition requirements in U.S. GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods or services to a customer. This ASU also amends the required disclosures of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for annual periods beginning after December 15, 2016, including interim periods within that period. Early adoption is not permitted under U.S. GAAP. The Company is determining its implementation approach and evaluating the potential impacts of the new standard on its existing revenue recognition policies and procedures. FASB ASU 2014-12, “Compensation - Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period,” was issued June 2014. This guidance was issued to resolve diversity in accounting for performance targets. A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition and should not be reflected in the award’s grant date fair value. Compensation cost should be recognized over the required service period, if it is probable that the performance condition will be achieved. The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. The Company does not anticipate a significant impact upon adoption. FASB ASU 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” which was issued September 2014. This provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company does not anticipate a significant impact upon adoption. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption. |
MARKETABLE SECURITIES
MARKETABLE SECURITIES | 6 Months Ended |
Feb. 29, 2016 | |
MARKETABLE SECURITIES [Text Block] | 4. MARKETABLE SECURITIES As at February 29, 2016 marketable securities consist of 375,000 common shares of Cheetah Oil & Gas Ltd. obtained through the disposal of the Company's oil and gas properties in Mississippi in 2010. The Company classified the securities owned as held-for-trade and recorded at fair value. The fair value of the common shares of Cheetah Oil & Gas Ltd. was $0.01 per share as at February 29, 2016 (August 31, 2015 - $0.01). As at February 29, 2016 marketable securities consist of 436,000 common shares of Lexaria Corp. obtained through Definitive Agreements as per Note 6. The Company classified the securities owned as held-for-trade and recorded at fair value. The fair value of the common shares of Lexaria Corp. was $0.09 per share as at February 29, 2016. |
LONG TERM INVESTMENTS
LONG TERM INVESTMENTS | 6 Months Ended |
Feb. 29, 2016 | |
LONG TERM INVESTMENTS [Text Block] | 5. LONG TERM INVESTMENTS Global Solar Water Power Systems Inc. (“GSWPS”) On February 28, 2010, the Company entered into an Asset and Share Purchase Agreement with the Company’s former chief technical officer - Mr. Mark Snyder to acquire up to 20% ownership interest of GSWPS. During the year ended August 31, 2013, based on the management’s assessment of GSWPS’s current operations, the Company decided to write down long-term investment in GSWPS to $1. Pro Eco Energy USA Ltd. During the year ended August 31, 2008, the Company purchased 900,000 shares in Pro Eco Energy USA Ltd. (“Pro Eco Energy”) for $45,000. During the year ended August 31, 2014, the Company sold its investment in Pro Eco Energy to Western Standard Energy Corp. for $40,000. During the year ended August 31, 2015, 600,000 shares of Pro Eco Energy was returned to the Company and the receivable from Western Standard Energy Corp. was settled. As at February 29, 2016 the Company owns 600,000 common shares of Pro Eco Energy, with carrying amount of $22,182, which represented 6.55% ownership. The Company has no significant influence in Pro Eco Energy. |
INVENTORY
INVENTORY | 6 Months Ended |
Feb. 29, 2016 | |
INVENTORY [Text Block] | 6. INVENTORY During the fiscal year August 31, 2015, the Company launched a new product line V-Love TM TM TM |
RELATED PARTIES TRANSACTION
RELATED PARTIES TRANSACTION | 6 Months Ended |
Feb. 29, 2016 | |
RELATED PARTIES TRANSACTION [Text Block] | 7. RELATED PARTIES TRANSACTION For the six months ended February 29, 2016, the Company was party to the following related party transactions: • Paid/accrued $39,000 (February 28, 2015: $39,000) to the President of the Company in consulting fees. • Paid/accrued $45,000 CAD (February 28, 2015: $45,000 CAD) in consulting fees to a company controlled by the CFO of the Company. • $108,098 (August 31, 2015: $76,288) was payable to the President and a company controlled by a CFO of the Company. • Incurred share based compensation expenses of $24,404 in relation to stock options issued to key management personnel (February 28, 2015: $103,111). The related party transactions are recorded at the exchange amount established and agreed to between the related parties. |
COMMON STOCK
COMMON STOCK | 6 Months Ended |
Feb. 29, 2016 | |
COMMON STOCK [Text Block] | 8. COMMON STOCK On February 4, 2016, the Company’s Board has appointed Olivier Vincent as an Advisor the Board of Directors and a consultant for a term of one year. The Company issued 100,000 common shares at an exercise price of $0.05 per share. As at February 29, 2016 the Company had 71,608,460 shares issued and outstanding and August 31, 2015, the Company had 71,508,460 shares issued and outstanding. |
STOCK OPTIONS AND WARRANTS
STOCK OPTIONS AND WARRANTS | 6 Months Ended |
Feb. 29, 2016 | |
STOCK OPTIONS AND WARRANTS [Text Block] | 9. STOCK OPTIONS AND WARRANTS Stock Options On July 15, 2014, the shareholders approved and adopted at the Annual General Meeting the Company’s 2014 Stock Option Plan. On April 14, 2011, the shareholders approved and adopted at the Annual General Meeting to consolidate the Company’s 2007 Equity compensation plan and the Company’s 2010 Equity Compensation Plan into a new Company 2011 Stock Option Plan. The purpose of these Plans is to advance the interests of the Corporation, through the grant of Options, by providing an incentive mechanism to foster the interest of eligible persons in the success of the Corporation and its affiliates; encouraging eligible persons to remain with the Corporation or its affiliates; and attracting new Directors, Officers, Employees and Consultants. On November 3, 2014 the Company granted 2,100,000 stock options to directors, officers, and consultant of the Company with an exercise price of $0.10 vested immediately, expiring November 3, 2019. On November 18, 2014, the Company granted 100,000 stock options to consultant of the Company with an exercise price of $0.10 vested immediately, expiring November 13, 2019. On October 23, 2015, the Company granted 1,850,000 stock options to directors, officers and consultant of the Company with an exercise price of $0.05 vested immediately, expiring October 23, 2020. On February 4, 2016, the Company granted 100,000 stock options to Advisor of the Board of the Company with an exercise price of $0.05 vested immediately, expiring February 4, 2021. For the six months ended February 29, 2016, the Company recorded $37,107 (February 28, 2015 – $177,596) stock based compensation expenses which has been included in consulting fees. A summary of the changes in stock options for the six months ended February 29, 2016 is presented below: Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2015 3,955,000 $ 0.20 Cancelled (1,550,000 ) 0.16 - 0.70 Expired (655,000 ) 0.15 - 0.20 Granted 1,950,000 0.05 Balance, February 29, 2016 3,700,000 $ 0.07 The fair value of options granted has been estimated as of the date of the grant by using the Black-Scholes option pricing model with the following assumptions: February 29, 2016 August 31, 2015 Expected volatility 220%- 216% 216%- 219% Risk-free interest rate 1.25%- 1.43% 1.63%- 1.79% Expected life 5.00 years 5.00 years Dividend yield 0.00% 0.00% Estimated fair value per option $0.01 -$0.05 $0.05 -$0.07 The Company has the following options outstanding and exercisable. February 29, 2016 Options outstanding Options exercisable Number Remaining Exercise Number Exercise Exercise prices of shares contractual Price of shares Price life exercisable $0.05 100,000 4.94 years $0.05 100,000 $0.05 $0.05 1,800,000 4.65 years $0.05 1,800,000 $0.05 $0.15 150,000 0.02 years $0.15 100,000 $0.15 $0.10 1,050,000 3.68 years $0.10 1,600,000 $0.10 $0.25 50,000 0.25 years $0.25 50,000 $0.25 $0.06 $0.06 550,000 2.68 years $0.06 550,000 3,700,000 3.84 years $0.07 3,700,000 $0.07 August 31, 2015 Options outstanding Options exercisable Remaining Number Number contractual Exercise of shares Exercise Exercise prices of shares life price exercisable Price $0.10 100,000 4.22 years $0.10 100,000 $0.10 $0.10 1,600,000 4.18 years $0.10 1,600,000 $0.10 $0.50 50,000 3.60 years $0.50 50,000 $0.50 $0.70 500,000 3.57 years $0.70 500,000 $0.70 $0.35 50,000 3.43 years $0.35 50,000 $0.35 $0.16 250,000 3.37 years $0.16 250,000 $0.16 $0.06 550,000 3.18 years $0.06 550,000 $0.06 $0.15 555,000 0.45 years $0.15 555,000 $0.15 $0.15 150,000 0.52 years $0.15 150,000 $0.15 $0.20 100,000 0.19 years $0.20 100,000 * $0.20 $0.25 50,000 0.75 years $0.25 50,000 $0.25 3,955,000 3.09 years $0.20 3,955,000 $0.20 Warrants On December 16, 2015, the Company submitted to the CSE the Form 13 for extending two classes of warrants by two years with all other terms and conditions remaining the same. The Company approved the expiry extension from January 31, 2016 till January 31, 2018 on 1,871,000 warrants that remain outstanding as of February 29, 2016 from the non-brokered private placement that closed on January 31, 2014. The Company approved the expiry extension from February 13, 2016 till February 13, 2018 on 6,231,500 warrants that remain outstanding as of February 29, 2016 from the non-brokered private placement that closed on February 13, 2014. A summary of warrants as at February 29, 2015 and August 31, 2015 is as follows: Warrant Outstanding Weighted Average Number of warrant Exercise Price Balance, August 31, 2015 15,435,085 $ 0.14 Expired (708,945 ) 0.20 Balance, February 29, 2016 14,726,140 $ 0.13 Number Exercise Expiry Outstanding 1 Price Date 1,468,000 $0.10 November 26, 2016 1,438,800 $0.10 December 23, 2016 2,167,160 $0.15 January 31, 2018 7,227,340 $0.15 February 13, 2018 1,787,640 $0.10 and $0.15 after 24 months January 30, 2018 637,200 $0.10 and $0.15 after 24 months March 12, 2018 14,726,140 1. Each warrant entitles a holder to purchase one common share. |
COMMITMENTS OTHER
COMMITMENTS OTHER | 6 Months Ended |
Feb. 29, 2016 | |
COMMITMENTS OTHER [Text Block] | 10. COMMITMENTS – OTHER (a) The Company has a consulting agreement with the President of the Company for corporate administration and consulting services for $5,000 per month plus HST/GST on a continuing basis. Effective March 1, 2014, the Company entered into a new consulting contract with the consulting services at $6,500 per month plus GST. (b) On October 9, 2009, the Company entered into consulting agreement with BKB Management Ltd., a corporation organized under the laws of the Province of British Columbia. BKB Management Ltd. is a consulting company controlled by the chief financial officer of the Company. BKB Management provides management consulting services for CAD$4,500 per month plus HST/GST. Effective April 1, 2011, the consulting services are CAD$5,500 per month plus HST/GST. Effective March 1, 2014, the Company entered into a new consulting agreement with the consulting services at CAD$7,500 per month plus GST. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 6 Months Ended |
Feb. 29, 2016 | |
SUBSEQUENT EVENTS [Text Block] | 11. SUBSEQUENT EVENTS On March 9, 2016, The Company entered a binding letter of intent with a private nutritional vitamin/supplement company (the “Seller”) for the Company to acquire of 100% interest in the business of the private company being all assets pertaining to the business of producing, manufacturing, importing/exporting, testing, researching and developing, intellectual property, inventory, all equipment, permits, files and records containing technical support and all other information and contents pertaining to the operation of the business of private nutritional vitamin/supplement products (the “Business”). In accordance with the terms of a Definitive Purchase Agreement to be entered into between the Company and the Seller, The Company will acquire a 100% ownership interest and operations in the Business upon the signing of the Definitive Purchase Agreement. The purchase price shall be payable as follows: a. The Company will pay to Seller, on the date of closing of the Definitive Purchase Agreement, the amount of $300,000 in cash; b. On or before six months after the closing of the Definitive Purchase Agreement, the Company shall make a cash payment of $25,000 ; c. On or before the first anniversary of the closing of the Definitive Purchase Agreement, the Company shall make a final cash payment for $25,000 |
Summary of Significant Accounti
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Feb. 29, 2016 | |
Basis of Presentation [Policy Text Block] | a) Basis of Presentation The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q and Article 10 of SEC Regulation S-X. They do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended August 31, 2015. The Company early adopted Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. This standard removes all incremental financial reporting requirements from U.S. generally accepted accounting principles for development stage entities, including the removal of Topic 915 from the FASB Accounting Standards Codification. Upon adoption, the Company no longer reports its operations as a development stage entity and eliminated all inception to date information. |
Accounting Estimates [Policy Text Block] | b) Accounting Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to revenue recognition, inventory valuation, and stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions. |
Recently Adopted Accounting Pronouncements [Policy Text Block] | c) Recently Adopted Accounting Pronouncements In June 2014, the FASB issued Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation (“ASU 2014-10”). The amendments in ASU 2014-10 remove all incremental financial reporting requirements from GAAP for development stage entities, including the removal of Topic 915, Development Stage Entities, from the FASB Accounting Standards Codification. ASU 2014-10 is effective for the first annual period beginning after December 15, 2014. Early adoption is permitted and the Company adopted ASU 2014-10 in the fourth quarter of 2015 which consisted principally of removing inception to date information on the Company’s statements of operations, equity and cash flows as well as other inception to date disclosures in the notes to its financial statements. |
New Accounting Pronouncements [Policy Text Block] | d) New Accounting Pronouncements FASB ASU 2014-09, “Revenue from Contracts with Customers,” was issued May 2014 and updates the principles for recognizing revenue. The ASU will supersede most of the existing revenue recognition requirements in U.S. GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods or services to a customer. This ASU also amends the required disclosures of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for annual periods beginning after December 15, 2016, including interim periods within that period. Early adoption is not permitted under U.S. GAAP. The Company is determining its implementation approach and evaluating the potential impacts of the new standard on its existing revenue recognition policies and procedures. FASB ASU 2014-12, “Compensation - Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period,” was issued June 2014. This guidance was issued to resolve diversity in accounting for performance targets. A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition and should not be reflected in the award’s grant date fair value. Compensation cost should be recognized over the required service period, if it is probable that the performance condition will be achieved. The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. The Company does not anticipate a significant impact upon adoption. FASB ASU 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” which was issued September 2014. This provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company does not anticipate a significant impact upon adoption. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption. |
STOCK OPTIONS AND WARRANTS (Tab
STOCK OPTIONS AND WARRANTS (Tables) | 6 Months Ended | 12 Months Ended |
Feb. 29, 2016 | Aug. 31, 2015 | |
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2015 3,955,000 $ 0.20 Cancelled (1,550,000 ) 0.16 - 0.70 Expired (655,000 ) 0.15 - 0.20 Granted 1,950,000 0.05 Balance, February 29, 2016 3,700,000 $ 0.07 | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | February 29, 2016 August 31, 2015 Expected volatility 220%- 216% 216%- 219% Risk-free interest rate 1.25%- 1.43% 1.63%- 1.79% Expected life 5.00 years 5.00 years Dividend yield 0.00% 0.00% Estimated fair value per option $0.01 -$0.05 $0.05 -$0.07 | |
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] | February 29, 2016 Options outstanding Options exercisable Number Remaining Exercise Number Exercise Exercise prices of shares contractual Price of shares Price life exercisable $0.05 100,000 4.94 years $0.05 100,000 $0.05 $0.05 1,800,000 4.65 years $0.05 1,800,000 $0.05 $0.15 150,000 0.02 years $0.15 100,000 $0.15 $0.10 1,050,000 3.68 years $0.10 1,600,000 $0.10 $0.25 50,000 0.25 years $0.25 50,000 $0.25 $0.06 $0.06 550,000 2.68 years $0.06 550,000 3,700,000 3.84 years $0.07 3,700,000 $0.07 | August 31, 2015 Options outstanding Options exercisable Remaining Number Number contractual Exercise of shares Exercise Exercise prices of shares life price exercisable Price $0.10 100,000 4.22 years $0.10 100,000 $0.10 $0.10 1,600,000 4.18 years $0.10 1,600,000 $0.10 $0.50 50,000 3.60 years $0.50 50,000 $0.50 $0.70 500,000 3.57 years $0.70 500,000 $0.70 $0.35 50,000 3.43 years $0.35 50,000 $0.35 $0.16 250,000 3.37 years $0.16 250,000 $0.16 $0.06 550,000 3.18 years $0.06 550,000 $0.06 $0.15 555,000 0.45 years $0.15 555,000 $0.15 $0.15 150,000 0.52 years $0.15 150,000 $0.15 $0.20 100,000 0.19 years $0.20 100,000 * $0.20 $0.25 50,000 0.75 years $0.25 50,000 $0.25 3,955,000 3.09 years $0.20 3,955,000 $0.20 |
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block] | Warrant Outstanding Weighted Average Number of warrant Exercise Price Balance, August 31, 2015 15,435,085 $ 0.14 Expired (708,945 ) 0.20 Balance, February 29, 2016 14,726,140 $ 0.13 | |
Schedule of Share Based Payment Award Equity Note Warrants or Rights Valuation Assumptions [Table Text Block] | Number Exercise Expiry Outstanding 1 Price Date 1,468,000 $0.10 November 26, 2016 1,438,800 $0.10 December 23, 2016 2,167,160 $0.15 January 31, 2018 7,227,340 $0.15 February 13, 2018 1,787,640 $0.10 and $0.15 after 24 months January 30, 2018 637,200 $0.10 and $0.15 after 24 months March 12, 2018 14,726,140 |
ORGANIZATION (Narrative) (Detai
ORGANIZATION (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016shares | |
Organization 1 | 200,000,000 |
GOING CONCERN UNCERTAINTY (Narr
GOING CONCERN UNCERTAINTY (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016USD ($) | |
Going Concern Uncertainty 1 | $ 303,966 |
Going Concern Uncertainty 2 | 1,301,654 |
Going Concern Uncertainty 3 | $ 12,219,062 |
MARKETABLE SECURITIES (Narrativ
MARKETABLE SECURITIES (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016USD ($)$ / sharesshares | |
Marketable Securities 1 | shares | 375,000 |
Marketable Securities 2 | $ / shares | $ 0.01 |
Marketable Securities 3 | $ | $ 0.01 |
Marketable Securities 4 | shares | 436,000 |
Marketable Securities 5 | $ / shares | $ 0.09 |
LONG TERM INVESTMENTS (Narrativ
LONG TERM INVESTMENTS (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016USD ($)shares | |
Long Term Investments 1 | 20.00% |
Long Term Investments 2 | $ 1 |
Long Term Investments 3 | shares | 900,000 |
Long Term Investments 4 | $ 45,000 |
Long Term Investments 5 | $ 40,000 |
Long Term Investments 6 | shares | 600,000 |
Long Term Investments 7 | shares | 600,000 |
Long Term Investments 8 | $ 22,182 |
Long Term Investments 9 | 6.55% |
INVENTORY (Narrative) (Details)
INVENTORY (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016USD ($) | |
Inventory 1 | $ 31,539 |
Inventory 2 | 37,066 |
Inventory 3 | 14,014 |
Inventory 4 | 0 |
Inventory 5 | 7,515 |
Inventory 6 | 0 |
Inventory 7 | 4,608 |
Inventory 8 | $ 5,364 |
RELATED PARTIES TRANSACTION (Na
RELATED PARTIES TRANSACTION (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016USD ($) | |
Related Parties Transaction 1 | $ 39,000 |
Related Parties Transaction 2 | 39,000 |
Related Parties Transaction 3 | 45,000 |
Related Parties Transaction 4 | 45,000 |
Related Parties Transaction 5 | 108,098 |
Related Parties Transaction 6 | 76,288 |
Related Parties Transaction 7 | 24,404 |
Related Parties Transaction 8 | $ 103,111 |
COMMON STOCK (Narrative) (Detai
COMMON STOCK (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016$ / sharesshares | |
Common Stock 1 | 100,000 |
Common Stock 2 | $ / shares | $ 0.05 |
Common Stock 3 | 71,608,460 |
Common Stock 4 | 71,508,460 |
STOCK OPTIONS AND WARRANTS (Nar
STOCK OPTIONS AND WARRANTS (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016USD ($)shares | |
Stock Options And Warrants 1 | shares | 2,100,000 |
Stock Options And Warrants 2 | $ | $ 0.10 |
Stock Options And Warrants 3 | shares | 100,000 |
Stock Options And Warrants 4 | $ | $ 0.10 |
Stock Options And Warrants 5 | shares | 1,850,000 |
Stock Options And Warrants 6 | $ | $ 0.05 |
Stock Options And Warrants 7 | shares | 100,000 |
Stock Options And Warrants 8 | $ | $ 0.05 |
Stock Options And Warrants 9 | $ | 37,107 |
Stock Options And Warrants 10 | $ | $ 177,596 |
Stock Options And Warrants 11 | shares | 1,871,000 |
Stock Options And Warrants 12 | shares | 6,231,500 |
COMMITMENTS OTHER (Narrative) (
COMMITMENTS OTHER (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016$ / moCAD / mo | |
Commitments Other 1 | $ / mo | 5,000 |
Commitments Other 2 | $ / mo | 6,500 |
Commitments Other 3 | 4,500 |
Commitments Other 4 | 5,500 |
Commitments Other 5 | 7,500 |
SUBSEQUENT EVENTS (Narrative) (
SUBSEQUENT EVENTS (Narrative) (Details) | 6 Months Ended |
Feb. 29, 2016USD ($) | |
Subsequent Events 1 | 100.00% |
Subsequent Events 2 | 100.00% |
Subsequent Events 3 | $ 300,000 |
Subsequent Events 4 | 25,000 |
Subsequent Events 5 | $ 25,000 |
Schedule of Share-based Compens
Schedule of Share-based Compensation, Stock Options, Activity (Details) | 6 Months Ended |
Feb. 29, 2016USD ($) | |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 1 | $ 3,955,000 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 2 | 0.20 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 3 | $ (1,550,000) |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 4 | 0.16 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 5 | 0.70 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 6 | $ (655,000) |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 7 | 0.15 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 8 | 0.20 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 9 | $ 1,950,000 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 10 | 0.05 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 11 | $ 3,700,000 |
Stock Options And Warrants Schedule Of Share-based Compensation, Stock Options, Activity 12 | 0.07 |
Schedule of Share-based Payment
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) | 6 Months Ended |
Feb. 29, 2016USD ($)yr | |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1 | 220.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2 | 216.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3 | 216.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4 | 219.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5 | 1.25% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6 | 1.43% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7 | 1.63% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8 | 1.79% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9 | yr | 5 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 10 | yr | 5 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 11 | 0.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 12 | 0.00% |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 13 | $ 0.01 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 14 | 0.05 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 15 | 0.05 |
Stock Options And Warrants Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 16 | $ 0.07 |
Disclosure of Share-based Compe
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) | 6 Months Ended | 12 Months Ended |
Feb. 29, 2016USD ($)yr | Aug. 31, 2015USD ($)yr | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1 | $ 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2 | $ 100,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3 | yr | 4.94 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4 | $ 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5 | 100,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6 | 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7 | 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8 | $ 1,800,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9 | yr | 4.65 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10 | $ 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11 | 1,800,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12 | 0.05 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13 | 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14 | $ 150,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15 | yr | 0.02 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16 | $ 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17 | 100,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18 | 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19 | 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20 | $ 1,050,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21 | yr | 3.68 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23 | 1,600,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24 | 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25 | 0.25 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26 | $ 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27 | yr | 0.25 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28 | $ 0.25 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29 | 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30 | 0.25 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31 | 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31 | 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32 | $ 550,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33 | yr | 2.68 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34 | $ 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35 | 550,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36 | $ 3,700,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37 | yr | 3.84 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 39 | 3,700,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 40 | $ 0.07 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2 | $ 100,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3 | yr | 4.22 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5 | 100,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6 | 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7 | 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8 | $ 1,600,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9 | yr | 4.18 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10 | $ 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11 | 1,600,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12 | 0.10 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13 | 0.50 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14 | $ 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15 | yr | 3.6 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16 | $ 0.50 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17 | 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18 | 0.50 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19 | 0.70 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20 | $ 500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21 | yr | 3.57 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22 | $ 0.70 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23 | 500,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24 | 0.70 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25 | 0.35 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26 | $ 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27 | yr | 3.43 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28 | $ 0.35 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29 | 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30 | 0.35 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31 | 0.16 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32 | $ 250,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33 | yr | 3.37 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34 | $ 0.16 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35 | 250,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36 | 0.16 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37 | 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38 | $ 550,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 39 | yr | 3.18 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 40 | $ 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 41 | 550,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 42 | 0.06 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 43 | 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 44 | $ 555,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 45 | yr | 0.45 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 46 | $ 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 47 | 555,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 48 | 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 49 | 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 50 | $ 150,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 51 | yr | 0.52 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 52 | $ 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 53 | 150,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 54 | 0.15 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 55 | 0.20 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 56 | $ 100,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 57 | yr | 0.19 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 58 | $ 0.20 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 59 | 100,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 60 | 0.20 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 61 | 0.25 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 62 | $ 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 63 | yr | 0.75 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 64 | $ 0.25 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 65 | 50,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 66 | 0.25 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 67 | $ 3,955,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 68 | yr | 3.09 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 69 | $ 0.20 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 70 | 3,955,000 | |
Stock Options And Warrants Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 71 | $ 0.20 |
Schedule of Stockholders' Equit
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) | 6 Months Ended |
Feb. 29, 2016USD ($) | |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1 | $ 15,435,085 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2 | 0.14 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3 | $ (708,945) |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4 | 0.20 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5 | $ 14,726,140 |
Stock Options And Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6 | 0.13 |
Schedule of Share Based Payment
Schedule of Share Based Payment Award Equity Note Warrants or Rights Valuation Assumptions (Details) | 6 Months Ended |
Feb. 29, 2016USD ($)mo | |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 1 | $ 1,468,000 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 2 | 0.10 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 3 | 1,438,800 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 4 | 0.10 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 5 | 2,167,160 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 6 | 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 7 | 7,227,340 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 8 | 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 9 | 1,787,640 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 10 | 0.10 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 11 | $ 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 12 | mo | 24 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 13 | $ 637,200 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 14 | 0.10 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 15 | $ 0.15 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 16 | mo | 24 |
Stock Options And Warrants Schedule Of Share Based Payment Award Equity Note Warrants Or Rights Valuation Assumptions 17 | $ 14,726,140 |